Escolar Documentos
Profissional Documentos
Cultura Documentos
Functional assessment in
rheumatic diseases
Whats new?
There has recently been a shift in the focus of patient
outcomes towards the inclusion of some method for
allowing patients to assign relative values to different
activities and outcomes or to specify the activities or
limitations of most importance to them
Alison Carr
Abstract
Standardized assessments of general physical function (e.g. walking unaided) and the ability to perform tasks of daily living are widely used
in rheumatology, both in clinical practice to assess disease severity and
progression, and in clinical research to evaluate the effectiveness of
treatment. Some measure of physical function is now included in the
core data set recommended for inclusion in all clinical trials in rheumatology. Several different methods and tools are available for measuring
function and most have been extensively validated for use in research.
These vary from directly observed performance of activities such as walking, sitting and standing, to patient-completed questionnaires of the
perceived difficulty they experience in performing daily living activities
or undertaking roles. This article reviews the different approaches used,
together with their advantages and disadvantages.
Keywords physical function; disability; outcome measures; patient outcomes; arthritis; activities of daily living
Observed measures (e.g. timed walk, step test) have the advantage of being measures of performance, largely independent of
patients perceptions or interpretations of disability. However,
this lack of context means that they are not necessarily good
measures of functional disability (i.e. how disabled the patient
is in performing daily living tasks or fulfilling his or her role).
They measure whether patients are capable of walking a certain
distance or climbing stairs, rather than whether they actually do
this in their own social environment.
Classification systems such as the American College of Rheumatology Revised Criteria for the Classification of Global Functional
MEDICINE 34:9
360
Rheumatoid arthritis
Stanford Health Assessment
Questionnaire (HAQ) (Disability
Index)
Individually Weighted HAQ
Osteoarthritis
Western Ontario and McMaster
Universities Osteoarthritis Index
(WOMAC)
AUSCAN (osteoarthritis hand
index)
Indices of Clinical Severity
(Lesquene) (for hip and knee
osteoarthritis)
Ankylosing spondylitis
Bath Ankylosing Spondylitis
Functional Index (BASFI)
Health Assessment
Questionnairefor
Spondyloarthropathies (HAQ-S)
Back pain
Rowland Morris Pain
Questionnaire
Oswestry Low Back Pain
DisabilityQuestionnaire
Upper limb
Disabilities of Arms, Shoulder
andHand (DASH)
Content
Source
Intensity of pain
Limitation of activities of daily living
Intensity of pain
Limitation of activities of daily living
Limitation of social activities
www.iwh.on.ca
Am J Ind Med 1996; 29: 6028.
Table 1
Class IV
Table 2
MEDICINE 34:9
361
measure change within an individual patient, standardized measures (e.g. the original HAQ, WOMAC, AIMS) have been preferred over individualized measures because of the perception
that the data are easier to analyse. A major disadvantage of any
patient-reported measure is that it provides no clear idea of what
constitutes an important change in function. Thus, a difference
in reported function between two groups participating in a clinical trial may be statistically significant but may not be detectable
by the patient, or, if detectable, may not be large enough for the
patient to consider one treatment more effective than another.
Clinical practice
There are three potential uses for functional measures in routine
clinical practice:
screening for specific functional problems that might be amenable to treatment or help from social services
informing clinical decision-making about the activity and
severity of disease and the most appropriate interventions
monitoring the effects of care.
Despite these potential advantages, functional measures are not
used universally in routine clinical practice. Several barriers to
their use have been identified, including concerns about cost,
feasibility and clinical relevance, suspicion that some measure
aspects of health outside the traditional remit of medical care,
and problems interpreting the results in a clinically meaningful
manner. When functional measures are used in rheumatology, it
is generally for longitudinal monitoring of disease and treatment
effects.
Many questionnaire-based measures have resource and
time implications that make them impractical for clinical use;
for example, questionnaires may be time-consuming, and
some patients may require help in completing them because
of problems with language or literacy or difficulty holding
a pen, or because they have forgotten their reading glasses.
Even when the questionnaire is relatively brief and can be
completed by the patient, it may not be easy to score it in a
clinical setting, and lack of familiarity with scoring systems
makes it difficult to interpret the scores obtained. The inclusion
of items of no relevance or importance to individual patients
(see above) limits the usefulness of these measures in iden
tifying specific problems of the patient and in informing clinical decision-making.
Measures that have been designed specifically for clinical use
can be used as the basis for the clinical consultation and in identifying patients priorities for treatment outcomes. An example is
the Disease Repercussion Profile (DRP),4 which assesses function in the context of patient-perceived handicap. In a recent trial
in 200 patients with rheumatoid arthritis (RA), patients whose
treatment was based on their results from the DRP exhibited
similar treatment outcomes (in terms of disease control) over
a 12-month period but were significantly more satisfied with
their treatment than those who underwent a more traditional
consultation.5
References
1 Hochberg M C, Chang R W, Dwosh I, Lindsey S, Pincus T, Wolfe F.
The American College of Rheumatology 1991 revised criteria for
the classification of global functional status in rheumatoid arthritis.
Arthritis Rheum 1992; 35: 498502.
2 Meenan R F, Mason J H, Anderson J J et al. AIMS2: the content and
properties of a revised and expanded Arthritis Impact Measurement
Scales health status questionnaire. Arthritis Rheum 1992; 35: 110.
3 Tugwell P, Bombardier C, Buchanan W W et al. The MACTAR Patient
Preference Disability Questionnaire: an individualised approach
for assessing improvement in physical disability in clinical trials in
rheumatoid arthritis. J Rheumatol 1987; 14: 44651.
4 Carr A J. A patient-centred approach to evaluation and treatment in
rheumatoid arthritis. Br J Rheumatol 1996; 35: 92132.
5 Carr A J, Hughes R A, Stowers K, Sheasby J, Wright C, Barlow J.
Disease management based on individual patient preferences and
priorities: a randomised controlled trial in rheumatoid arthritis.
Arthritis Rheum 2001; 44: S390.
6 Schwartz C E, Sprangers M A G. Methodological approaches for
assessing response shift in longitudinal health-related quality of life
assessment. Soc Sci Med 1999; 48: 153148.
MEDICINE 34:9
362
Further reading
Bellamy N. Musculoskeletal clinical metrology. Lancaster: Kluwer
Academic, 1993.
(A comprehensive guide to all forms of clinical measurement in
rheumatology, with practical tips for clinical practice and research;
contains reproductions of some functional measures.)
Delamothe T, ed. Outcomes into clinical practice. London: BMJ
Publishing Group, 1994.
(Includes interesting examples of how outcome assessment can be
incorporated into routine clinical practice.)
Higginson I J, Carr A J. Measuring quality of life: using quality of life
measures in the clinical setting. BMJ 2001; 322: 1297300.
(Practical, step-by-step advice on how to incorporate questionnaire
measures into routine clinical practice.)
McDowell I, Newell C. Measuring health: a guide to rating scales and
questionnaires. 2nd ed. Oxford: Oxford University Press, 1996.
(A rsum of rating scales, including descriptions, a review
of their development and an assessment of their validity and
reliability).
MEDICINE 34:9
Practice points
Functional assessments in rheumatic diseases can take the
form of observations of performed activities or patient selfreports (questionnaires) of difficulty performing activities of
daily living
Such assessments have traditionally been used in research,
but can also provide useful data in clinical practice to
evaluate the effectiveness of treatment or guide clinical
decision-making
Using functional measures in clinical practice requires careful
consideration of issues such as feasibility, interpretability of
scores and how the data are to be used
One of the greatest challenges of measuring function over
time is response shift changes in the way patients perceive
and calibrate functional disability in relation to age, duration
and activity of disease, and expectations
363